Investors and corporations are willing to pay a high price for stakes in cannabis companies that currently generate little revenue (and whose product remains illegal at the federal level) because of their future potential. So how do you go about valuing a pot stock? The best comparison may lie in the biotechnology space. CLICK HERE.
